Interruption médicale de grossesse pour retard de croissance intra-utérin isolé au-delà de 24 SA et de 450 g - Nantes Université Accéder directement au contenu
Article Dans Une Revue Gynécologie Obstétrique Fertilité & Sénologie Année : 2023

Interruption médicale de grossesse pour retard de croissance intra-utérin isolé au-delà de 24 SA et de 450 g

Résumé

Introduction. - Fetal growth restriction (FGR) is an obstetric complication responsible for increased perinatal morbidity and mortality. In some severe and early FGR situations, termination of pregnancy (TOP) may be considered. The main objective of our study was to describe the population of fetuses for whom a TOP was performed for isolated FGR beyond 24 days' gestation and for a birth weight > 450 g and to analyze the immediate outcome, at 2 and 5 years, of term-and weight-matched neonates born in a context of severe FGR after 24 weeks' gestation and over 450 g. Material and methods. - We conducted an observational, descriptive, retrospective, uni-centric study between 2008 and 2018. The primary endpoint was survival at maternity discharge, 2 years and 5 years in these children. Secondary endpoints were assessment of immediate and longer-term postnatal morbidity. Twenty-five patients (36%) were selected for the study with a fetus weight > 450 g and term > 24 weeks. Each fetus with an TOP was matched (on gestational age and weight) with two live-born children from the perinatal network cohort to assess immediate discharge outcome, and then at 2 and 5 years. Results. - The mortality rate was 24%. In neonatal management, for 67% (n = 17) of the newborns the evolution was complicated by death or at least two sequelae (bronchopulmonary dysplasia, hyaline membrane disease stage >= 2, intraventricular of grade 3 and 4, ulcerative colitis requiring surgery, retinopathy of prematurity stage 2 and more) at discharge. In 32% (n = 8) of cases, there was at least one sequela at discharge. Regardless of gestational age at birth, development at 2 years was normal for 48% (n = 11/23) of them and abnormal for 22% (n = 5) and development at 5 years was normal for 56% (n = 9/16) of them and abnormal for 19% (n = 5). Conclusion. - An ultrasound evaluation in a reference center as well as additional information by the obstetrician and neonatologist ensures the most appropriate informed involvement of the couple in the medical decisions before and after birth.
Fichier non déposé

Dates et versions

hal-04239586 , version 1 (12-10-2023)

Identifiants

Citer

J. Guinamant, Norbert Winer, Jean-Christophe Rozé, C. Arthuis. Interruption médicale de grossesse pour retard de croissance intra-utérin isolé au-delà de 24 SA et de 450 g. Gynécologie Obstétrique Fertilité & Sénologie, 2023, 51 (3), pp.166-171. ⟨10.1016/j.gofs.2022.11.003⟩. ⟨hal-04239586⟩
12 Consultations
4 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More